TickerFacts.

Heartflow, Inc. (HTFL): Cost of Revenue

Annual figures by period end, from SEC filings.

$40.84M
Year ended 2025-12-31
$42.24M
Trailing 12 months to 2026-06-30
2023-12-31: $29.12M2024-12-31: $31.36M2025-12-31: $40.84M$40.84M
2023-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$40.84M+30.2%2026-03-18, From 2025-01-01
2024-12-31$31.36M+7.7%2026-03-18, From 2024-01-01
2023-12-31$29.12Mn/a2026-03-18, From 2023-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Heartflow, Inc. (HTFL)2025-12-31$40.84M+30.2%
SI-BONE, Inc. (SIBN)2025-12-31$41.05M+17.1%
Neuronetics, Inc. (STIM)2025-12-31$76.85M+270.7%
Treace Medical Concepts, Inc. (TMCI)2025-12-31$42.94M+4.5%
InfuSystem Holdings, Inc (INFU)2025-12-31$63.14M-2.0%
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$49.65M+1.2%
Orthopediatrics Corp (KIDS)2025-12-31$63.69M+13.5%
Lemaitre Vascular Inc (LMAT)2025-12-31$71.06M+3.0%
Orasure Technologies Inc (OSUR)2025-12-31$66.82M-37.2%

Compare HTFL, SIBN, STIM, TMCI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗